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Introduction
Similar to the increases seen in athletic participation within the United 
States, female athletic participation continues to increase worldwide. 
An examination of the participation of women in the Olympic Games 
over the last century appears to support this.  Female participation 
has steadily increased, most dramatically over the past 50 years. 
The most recent summer Olympics in Beijing (2008) saw the highest 
rate of female participation with a total of 4 746 women participat-
ing, representing a record 42% of athletes.  Women remain under-
represented in sport in South Africa, but consistent and progressive 
rates of participation are being appreciated throughout the country. 
As rates of female participation continue to increase throughout the 
country, it is important to consider the unique health challenges that 
female athletes may encounter.
For most female athletes, sports participation is a positive 
experience, providing improved physical fitness, enhanced self-
esteem and better physical and mental health.1 However, this 
increased activity has also led to the emergence of a unique 
combination of medical problems and injuries specific to the female 
athlete.  This includes a unique triad to conditions specific to the 
female athlete that include energy availability, menstrual function 
and bone mineral density.
Definitions
In 1992, the American College of Sports Medicine (ACSM) recog-
nised the association of three distinct entities with female athletes. 
The female athlete triad was originally defined as the combination 
of disordered eating, amenorrhoea and osteoporosis found in physi-
cally active girls and women.2  Further research since then proved 
these entities to be far too narrow in scope, existing only at the ex-
treme endpoint of the disorder’s spectrum.3  By 2007, the ACSM 
revised position statement modified the three components of the 
triad into energy availability, menstrual function and bone mineral 
density.4  Each of these components consists on a continuum from 
healthy to subclinical to pathological.  
Energy intake from diet is necessary for various physiological 
functions.  Energy expenditure is the energy expended by the 
body during normal daily activities and exercise training.  Energy 
availability defines the amount of energy remaining for physiological 
functions after expended from physical activity.  Decreased caloric 
consumption and/or increased exercise energy expenditure results 
in low energy available for normal physiology functions, including 
cellular maintenance, thermoregulation, growth and reproduction.  
Clinical eating disorders, namely anorexia nervosa, bulimia 
nervosa and eating disorders not otherwise specified, exist on the 
extreme end of this category.  However, these conditions carry a 
largely psychiatric component for diagnosis.5 A larger population 
of female athletes practise unhealthy eating and weight control 
behaviours with significant impact on their health without the 
psychiatric element.  Such subclinical eating disorders include 
prolonged fasting, low caloric diets, binge eating, purging, or the 
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Abstract
Female athletic participation continues to grow throughout the 
world.  This has many positive effects on health and well-being, 
but it has also led to a unique set of health problems.  The female 
athlete triad was first described in 1992 by the American College 
of Sports Medicine, consisting of disordered eating, amenorrhoea 
and osteoporosis.  An updated position stand was released in 
2007 that modified the components of the triad to energy avail-
ability, menstrual function and bone mineral density.  This article 
reviews the current definitions of the triad components, epide-
miology, pathophysiology, diagnosis and treatment.  Each of the 
components of the triad exists on a continuum from healthy to 
pathological.  Low energy availability, from either dietary restric-
tion or increased expenditure, is the factor that leads to the path-
ological states of menstrual function and bone mineral density. 
Athletes especially at risk are those in sports requiring leanness 
or low body weight.  Prevention and early recognition of triad 
disorders is crucial to ensure timely intervention and treatment. 
Treatment is centered on restoring energy availability to adequate 
levels (30 kcal.kg-1.d-1) to re-establish normal metabolic function-
ing. All those who work with female athletes must remain vigilant 
in the education, recognition and treatment of athletes at risk. 
Continued research and knowledge of the triad disorders aids 
the development of prevention and treatment strategies to allow 
women to continue to enjoy the benefits of regular exercise and 
physical activity throughout their lives.  
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utilisation of diet pills, laxatives and other supplements.  Other 
athletes unknowingly fail to meet their considerable exercise energy 
requirements due to time constraints, food availability issues or lack 
of appropriate nutritional knowledge.6
Amenorrhoea is the absence of menstrual cycles, and can be 
subdivided into primary and secondary amenorrhoea.  Primary 
amenorrhoea is the absence of menarche by age 15, whereas 
secondary amenorrhoea is an interruption of menses for greater 
than 3 months after the initiation of menarche.7  The ACSM 
updated position stand on the female athlete triad recognised 
other menstrual irregularities that cause an adverse effect to the 
female athlete’s health.4  Thus, the term menstrual dysfunction 
was employed as a component of the female athlete triad, which 
includes luteal suppression, anovulation and oligomenorrhoea in 
addition to primary and secondary amenorrhoea.  Oligomenorrhoea 
describes a prolonged menstrual cycle greater than 35 days.8 Both 
luteal suppression and anovulation are asymptomatic conditions, 
associated with either a shortened luteal phase or lack of ovulation 
respectively.  
Osteoporosis is a decrease in bone mass that increases the risk of 
fracture.9  This may be due to age-related decreases in bone mass, or the 
result of inadequate bone accumulation during growth and development 
resulting in a lower peak bone mass being attained.  The World Health 
Organization (WHO) criterion for diagnosing osteoporosis is a bone 
mineral density more than 2.5 standard deviations below the mean of 
young adults.10  Utilisation of this T-score was based on epidemiological 
data relating bone mineral density to fracture risk in postmenopausal 
women,11,12 thus it lacks external validity for evaluating adolescent 
or premenopausal women.  In 2005, the International Society for 
Clinical Densiometry (ISCD) recommended that bone mineral density 
for premenopausal women and children be expressed as a Z-score. 
A Z-score greater than or equal to 2.0 standard deviations below 
the mean of age- and sex-matched controls is defined as ‘low bone 
density below the expected age range’.13,14  Together the ISCD and 
ACSM defined osteoporosis in premenopausal women as having this 
low Z-score along with secondary clinical risk factors, including chronic 
malnutrition, eating disorders, hypogonadism, glucocorticoid exposure 
and previous fractures.4,13,14
Epidemiology
The prevalence of female athletes with abnormalities in energy 
availability, menstrual function and/or bone mineral density varies 
tremendously between studies.  Reported data show a range of 1 - 
62% of female athletes with an eating disorder,2,15 6 - 79% with men-
strual dysfunction,2,3,16 and 0 - 50% with low bone mineral density.17
Several factors have contributed to these broad results, including 
the wide range and ever-changing definitions of each component 
of the female athlete triad.  Utilising the strict DSM-IV diagnosis for 
clinical eating disorders yields a prevalence between 1% and 3%,18 
whereas the more ambiguous term ‘disordered eating’ opens up the 
diagnostic criteria, yielding larger prevalence outcomes between 
15% and 62%.1  Similarly, the expanded definition of menstrual 
dysfunction to include oligomenorrhoea, luteal suppression and 
anovulation has seen prevalence increase from 6% to as high as 
79%.16,19  Finally, studies utilising the WHO classification for bone 
mineral density found 22 - 50% of patients with osteopenia, and 
virtually 0% having osteoporosis.17  The new ISCD criterion utilizing 
Z-scores identified 10.7% of female athletes to have low bone 
mineral density below the expected age range.20  
Other aspects involved in the investigation of the female athlete 
triad result in an imprecise measurement of prevalence.  Diagnosis 
of low energy availability typically involves self-questionnaires.  Most 
questionnaires are designed for clinical eating disorders, such as 
the Eating Disorders Inventory (EDI or EDI-2) or the Eating Attitude 
Test (EAT),21 and focus mostly on the psychiatric component of the 
disease.  They do not take into account other subclinical causes of 
low energy availability, including excess exercise energy expenditure 
and abnormal eating behaviours.  This can be better assessed with 
documentation of energy balance through food logs and activity 
records.  However, both evaluations require self-reporting, with 
inherent limitations due to underreporting of symptoms.1
The heterogeneity of the population being investigated for the 
female athlete triad has also created discrepancies in prevalence. 
The age of an athlete significantly affects their risk for each 
component of the triad, as does their stage in growth, development 
and menarche.  Thus, comparing athletes over a wide range of 
ages during adolescence and pre-adulthood becomes problematic. 
In addition, because females develop at different rates, comparing 
them at similar ages can also cause difficulties.  
The level of competition also affects the epidemiological studies 
of the female athlete triad.  Comparison of elite athletes, collegiate 
athletes and recreational athletes has shown an increase risk for 
components of the female athlete triad with increasing level of 
competition.  A meta-analysis of 34 studies with 2 459 athletes found 
an increased risk of disordered eating with elite athletes, and that 
non-elite athletes, especially those in high school, were somewhat 
protected.22  Early start of sport-specific training and dieting, a 
sudden increase in training volume, and sports-related injury are 
also risk factors for the female athlete triad more commonly seen in 
higher-level athletics.23  The increased pressure for winning by the 
athletes, as well as coaches, parents and society in general, places 
these athletes at higher levels of competition at increased risk for 
behaviours associated with the female athlete triad.1
Different sports have different risk factors for the individual 
components of the female athlete triad.  Low energy availability is 
more commonly seen in sports that emphasise a lean physique 
or low body weight (Table I).2 Byrne et al.24 identified 31% of elite 
female athletes in ‘thin-build’ sports to have an eating disorder 
compared with 8% in the ‘normal-build’ athletes.  Thin-build athletes 
are those involved in sports emphasising leanness or low body 
weight (ballet, gymnastics, long distance running, swimming and 
diving), where normal-build athletes are those in sports with less 
emphasis on leanness (basketball, volleyball, hockey, softball).24 
Menstrual dysfunction is more common in endurance sports such 
as running, with prevalence up to 69%.25,26  High-impact sports 
such as basketball, volleyball and gymnastics20,27,28 are associated 
with higher bone mineral density than lower-impact sports such as 
TAbLE I.  Sport-specific risks to low energy availability
Category Examples
Sports subjectively scored Dance, figure skating, diving, 
gymnastics, aerobics
Sports emphasising low body 
weight
Distance running, cycling, cross-
country skiing
Sports requiring body 
contour-revealing clothing
Volleyball, swimming, diving, 
cross-country running, cross-
country skiing, track, cheerleading
Sports with weight categories Horse racing, martial arts, wres-
tling, rowing
Sports emphasising prepuber-
tal body habitus
Figure skating, gymnastics, diving
running and swimming.29  Consequently, studies examining single 
sports may either overestimate or underestimate the true overall 
prevalence of the female athlete triad.
Despite all the difficulties reporting on the female athlete triad, 
including inconsistent definitions, methodological issues and the 
heterogeneity of the population, three studies establish prevalence 
for the simultaneous diagnosis of all three components of the female 
athlete triad30-32 These studies utilised large, heterogeneous samples 
of athletes as well as a more validated definition of low energy 
availability, menstrual dysfunction and low bone mineral density. 
Disordered eating and menstrual dysfunction were determined from 
a questionnaire, while bone mineral density was evaluated via dual-
energy X-ray absorptiometry (DXA).  The resultant prevalence was 
between 1.2% and 4.3% of female athletes for all three components. 
However, these values are likely underrepresented because neither 
low energy availability nor subclinical menstrual disorders, including 
luteal suppression, anovulation and oligomenorrhoea, were part of the 
diagnostic criteria.  Also, as discussed previously, self-reporting has 
inherent bias.  Finally, although the prevalence is low for all components 
of the triad, one study31 found 6% of female athletes had two components 
of the female athlete triad and 18 - 24% had one component.
Pathophysiology
In addition to redefining the components of the female athlete triad, 
the ACSM focused on the pathogenesis of the female athlete triad. 
The majority of the current research on the female athlete triad cen-
tres on low energy availability as the key entity underlying the entire 
process.  
A specific aetiology has not been identified regarding the 
pathogenesis of eating disorders or low energy availability.33 
There likely is a complex relationship between social, cultural, 
demographic, environmental, biology, psychological and behavioural 
factors.34 Controversy exists regarding whether athletes have a 
higher prevalence of disordered eating behaviours when compared 
with non-athletes, with some studies showing increased prevalence 
in the athletic population,22,35,36 while others show no difference.37,38
However, there is evidence suggesting athletes face sport-
specific pressures that may trigger eating disorders in vulnerable 
athletes.  As discussed previously, sports with emphasis on low 
body weight place these athletes at increased risk for developing a 
clinical eating disorder.  In addition, increased training and practice 
associated with organised athletics may lead to inadvertent low 
energy availability.  Experiments have shown that dietary restriction 
increased hunger, but similar levels of energy deficiency by increased 
exercise expenditure did not increase appetite.39 As a result, athletes 
unknowingly do not increase their energy intake due to increased 
exercise expenditure due to a lack of a physiological response.40 
Energy availability is not just related to diet and exercise, but 
also dependent on other hormonal and physiological processes. 
Two different hormones, leptin and ghrelin, have been identified as 
potential regulators of metabolic rate and energy homeostasis.  The 
hormone leptin regulates the resting metabolic rate, and has been 
proposed as a marker of nutritional status.  Leptin is decreased in 
athletes with disordered eating and amenorrhoea.41 A leptin value 
of 1.85 mg has been identified as a minimum value to maintain a 
normal menstrual cycle.41 Ghrelin is a hormone produced in the 
stomach and gastrointestinal tract that acts as a metabolic signal 
for hunger and energy homeostasis.  De Souza et al.42 showed high 
levels of ghrelin in amenorrhoeic women indicate an energy deficit. 
Ghrelin may also play a physiological role in reproductive function 
via actions on the luteinising hormone (LH) pulsatility.43
Increased physical activity has been linked to the cessation of 
menses.16  This has been found as a result of a disruption in the 
pulsatile secretion of LH by the pituitary gland, which is caused by 
a disruption earlier in the pulsatile secretion of the gonadotropin-
releasing hormone by the hypothalamus.44  In multiple studies, 
Loucks showed that low energy availability is at the root of 
hypothalamic menstrual dysfunction.45-47  The threshold of energy 
availability necessary to maintain normal menstrual function in 30 
kcal.kg-1 lean body mass per day.45  Strenuous training alone is not 
enough to disrupt menstrual function, unless it is also accompanied 
by dietary restriction.  Normal cycles can be restored with increasing 
dietary intake; however, this is only accomplished with sustained 
increased intake, not simply one day of aggressive refeeding.46
Altered bone mineral density is related to deficiency in the 
hormones oestrogen and progesterone, as well as caloric deprivation 
and inadequate calcium intake.  The most important function of 
oestrogen on bone health is its suppressing effect of osteoclast 
activity.48  BMD declines as the number of missed menstrual cycles 
accumulates and these losses may not be fully reversible.49  A 
study by Ihle and Loucks showed that low energy availability may 
have a direct effect of bone.50  They demonstrated markers of 
bone formation and resorption changed negatively within 5 days in 
sedentary women exposed to low energy availability through dietary 
restriction or increased exercise energy expenditure.  It is plausible to 
expect similar results to be seen in an athletic population.  Additional 
work by Zanker has shown that low BMI and an oestrogen deficiency 
were associated with disruption of bone formation in amenorrhoeic 
women.51  However, there was a lack of correlation between 
serum levels of bone formation markers, BMI and serum oestradiol 
concentration in the eumenorrhoeic athletes, suggesting that there 
may be a threshold value of BMI, or serum oestradiol concentration, 
above which bone formation is not inﬂuenced by either of these 
variables.  In fact, markers of bone formation are low in athletes with 
menstrual dysfunction, suggesting that low bone formation is a result 
of undernutrition.
Additional studies have indicated that low energy availability 
affects other metabolites and hormones, such as insulin, growth 
hormone, insulin-like growth factor-1, cortisol and thyroid hormone.52 
These are all important for optimal bone health and metabolism 
independent of a hypo-oestrogenic state. 
Health consequences
The body compensates for low energy availability by decreasing 
the resting metabolic rate, resulting in decreased energy to other 
normal physiological mechanisms, such as cellular maintenance, 
thermoregulation, growth and reproduction.  Thus, although a sta-
ble body weight may be maintained, the health of the athlete is ad-
versely affected.  
Sustained low energy availability can have significant effects 
on health.  Undernutrition impairs both menstrual and skeletal 
heath.53 Additionally, several studies have shown medical effects 
and physical symptoms involving the dermatological, cardiovascular, 
endocrine, gastrointestinal, renal and central nervous systems 
(Table II).33,53-55  Montero et al.56 examined the effect of low energy 
availability on the immune system of the female athlete (Fig. 1). 
Increased exercise combined with low calorie intake seems to 
decrease immunocompetence, resulting in decreased endurance, 
decreased performance and increased chance of subclinical and 
clinical infections.  
The effect that low energy availability has on athletic performance 
varies depending on the severity and duration of the low energy state, 
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as well as the physical demands of the sport.57  Longer durations 
of restricted energy availability are associated with more dramatic 
negative effects on performance.57  Likewise, athletes in endurance 
sports with high energy demands (distance running, swimming, 
cycling, basketball) show more effects on performance than athletes 
in lower energy demand sports (gymnastics, diving, weightlifting).
The consequences of menstrual dysfunction have been well 
documented and include infertility, decreased immune function, 
increased cardiovascular risk factors and decreased bone 
mineral density with its associated increased risk of premature 
osteoporosis.58  It should be emphasised to athletes that menstrual 
dysfunction is not a normal response to athletic training.  Athletes 
may show little concern for disruption of their cycles and may even 
‘appreciate the break’.  However, this should be viewed as a clear 
indication that health is being compromised.  
An athlete’s bone mineral density is a reﬂection of her cumulative 
history of energy availability and menstrual status, in combination with 
genetics and other environmental factors.  It is important to always 
consider the current bone mineral density status and where it is 
moving along the spectrum.  Stress fractures occur more frequently in 
females who display menstrual irregularities and/or low bone mineral 
density.59,60  A premenopausal fracture not related to a significant 
traumatic event is a strong predictor for postmenopausal fractures.61 
Even with restoration of adequate energy availability and regular 
menses the loss of bone mineral density may not be fully reversible.
Screening and diagnosis of triad disorders
Screening for and diagnosis of the triad disorders can be challenging 
due to the symptoms and health consequences not always being 
readily apparent.  A high degree of suspicion and an understand-
ing of the relationship between the triad components are critical to 
diagnosis.  Many of the affected athletes are involved in those sports 
requiring leanness or thinness as an advantage in performance; 
however, individuals participating in any sport or regular physical ac-
tivity are also at risk.  Additionally, individuals of all levels may be at 
risk, not just the elite population.  Optimal screening times are during 
pre-participation physicals and during annual heath exams.  Other 
opportunities present when athletes are evaluated for related prob-
lems.  Any time an athlete presents with one component of the triad, 
they should be assessed for the others.
Energy availability/disordered eating
A high index of suspicion is necessary for the recognition and di-
agnosis of disordered eating behaviours.  Psychological or behav-
ioural characteristics may alert the physician or other member of the 
health care team.  Examples include: anxiety with eating or weight 
gain, unusual dieting behaviour, binging or secretive eating, social 
withdrawal, abuse of laxatives or other weight loss medications and 
over-exercising.62  Additionally, recognition of physical symptoms 
likely related to malnutrition and/or purging behaviours may be 
seen.62  Weight loss methods may include restriction of food intake, 
fasting, self-induced vomiting, diet pills, laxatives, diuretics and ex-
cessive exercise.62  Physical exam is important in the recognition of 
eating disorders, and should start with height, weight and vital signs. 
Orthostatic hypotension should also be assessed.  Other physical 
findings include cold or discoloured hands and feet, hypercaroten-
aemia, lanugo hair and parotid gland enlargement.  Laboratory as-
sessment should initially include a complete blood count with differ-
ential, chemistry profiles, erythrocyte sedimentation rate, C-reactive 
protein, thyroid function studies (and other sex steroid hormones de-
pending on physical findings) and a urinalysis.  An electrocardiogram 
should also be done to evaluate for any arrhythmias and prolonga-
tion of the QT interval.63
TAbLE II. Physical symptoms of athletes with eating disorders
Dermatological/dental Cardiovascular Endocrine Gastrointestinal
Hair loss Bradycardia Hypoglycaemia Swollen parotid glands
Lanugo hair Hypotension Delayed onset of puberty Constipation/diarrhoea
Dorsal hand callus or abrasions Menstrual dysfunction Postprandial distress
Dental and gum problems Stress fractures
Renal
Dehydration
Oedema
Electrolyte disturbances
Hypokalaemia
Muscle cramps
Metabolic alkalosis
CNS/other
Significant weight loss
Frequent weight ﬂuctuations
Extreme fatigue
Muscle weakness
Hyperactivity
Anaemia
Fig. 1.  Consequences of increased exercise and a low BMI in 
the female athlete.
54                                                                                                                   SAJSM  voL 23  No. 2  2011
Menstrual dysfunction
Similar to identification of eating disorders, a high degree of sus-
picion, thorough history taking and physical exam are important in 
identification of menstrual dysfunction.  Menstrual dysfunction com-
monly accompanies disordered eating, but if it continues after weight 
is restored to within 10% or normal, further workup for amenorrhoea 
is indicated.  Patients with functional hypothalamic amenorrhoea of-
ten have a normal physical exam, but may show vaginal atrophy on 
pelvic exam if hypo-oestrogenism is present.  Laboratory evaluation 
for secondary amenorrhoea should include a pregnancy test, gon-
adotropin measurement (FSH, LH), probating and thyroid studies.  If 
there is evidence of androgen excess on physical exam, free testos-
terone and dehydroepiandrosterone sulfate may be obtained.  Addi-
tional workup may be needed based on patient history and physical 
exam, as well as with cases of primary amenorrhoea.  Consultation 
with a physician experienced in reproductive medicine is recom-
mended if menses are not restored after 3 - 6 months of treatment.
bone mineral density
The gold standard for evaluation of bone mineral density is with 
DXA.  Current recommendations for evaluation with DXA include 
those athletes with a history of stress fractures, fractures with mini-
mal trauma, a history of hypo-oestrogenism, and disordered eating 
or eating disorders for a cumulative total of 6 months or more.64  It 
is important to remember that in normal female athletes, particularly 
those in weight-bearing sports, have bone mineral density measure-
ments 12 - 15% higher than non-athletes.20  Altered bone mineral 
density may be obvious in the athlete with a stress fracture or fragility 
fracture.  Additionally, affected athletes are also more likely to report 
sprains, strains and other soft-tissue injuries.65
Treatment recommendations
Prevention and treatment of the triad should employ a multidiscipli-
nary team for best results.  The health care team should include a 
physician, registered dietician and a mental health practitioner, espe-
cially for those athletes with eating disorders.  Additional team mem-
bers may include athletic trainers, an exercise physiologist, coaches, 
and parents and other family members.
Prevention
The best way to prevent the detrimental health effects of the triad 
components is through early recognition of athletes at risk and then 
incorporation of prompt education and intervention in those athletes. 
Special emphasis should be placed on optimising energy availabil-
ity and maximising bone mineral accumulation in younger athletes. 
Athletes should be counselled on appropriate nutritional require-
ments for their age.  Females of all ages should also be educated 
on the benefits of regular weight-bearing exercise for bone health. 
Athletes should be screened for menstrual dysfunction and educated 
on its immediate and long-term health negative health effects.
Treatment
The initial focus of treatment should be on modifying diet and exer-
cise behaviour to increase energy availability.  This may be accom-
plished by increasing energy intake, decreasing energy expenditure, 
or a combination of both.  The aim is to restore normal menstrual 
cycling and prevent a further loss of bone.  Energy availability should 
be increased to at least 30 kcal.kg-1 lean body mass per day, but 
increasing levels of energy availability over 45 kcal.kg-1 lean body 
mass per day may be necessary to increase bone mineral density.45 
It is important to ensure that adequate intake of the bone-building 
nutrients calcium (1 000 - 1 300 mg.d-1), vitamin D (400 - 800 IU.d-1) 
and vitamin K (60 - 90 μg.d-1) is maintained.66,67  Athletes in intense 
training also require greater protein intake than for the general popu-
lation (1.2 - 1.6 g.kg-1d-1).68  Affected athletes without clinical eating 
disorders should be referred to a dietician for nutritional counselling. 
Those athletes with clinical eating disorders require consultation with 
other care providers, as well as individual psychotherapy, cognitive 
behavioural, group and family therapy.  Increased energy availability 
continues until the resumption of menses and is maintained during 
training and competition.  Athletes need to maintain minimum crite-
ria to continue with training and competition.  Close follow-up and 
open communication with the entire health care team is essential. 
Athletes who fail to maintain appropriate levels of energy availability, 
refuse treatment, or fail to improve eating behaviour should be with-
held from training and competition to focus on their health.
In some athletes the addition of pharmacological therapy is 
beneficial in the treatment of triad disorders.  Athletes with low 
energy availability secondary to clinical eating disorders may benefit 
from antidepressant medications.  Antidepressants are also used in 
athletes with concomitant depression and anxiety disorders.69 The 
other established and recommended pharmacological treatments 
in athletes with the triad are aimed at maintenance and restoration 
of bone mineral density.  In females with functional hypothalamic 
amenorrhoea, hormonal therapy, commonly oral contraceptive 
pills (OCP) are used to protect bone mineral density.  When 
OCP are used to restore regular menstrual cycles, it will not 
normalise metabolic factors that impair bone formation, health 
and performance.  Therefore it is unlikely to fully reverse low 
bone mineral density in this population, and studies have shown 
inconsistent osteogenic effects with OCP.70,71  Current indications 
for the initiation of treatment with OCP are females older than 
age 16 years with declining bone mineral density and persistent 
functional hypothalamic amenorrhoea despite adequate energy 
availability, with the goal of minimising further bone loss.70  Agents 
for increasing bone mineral density, such as bisphosphonates and 
selective oestrogen receptor modulators, are not recommended 
for use in premenopausal women.71  Bisphosphonates have not 
been proven effective in women of childbearing age.72  Additionally, 
they may be stored in the bone for many years, raising concern for 
possible harm to a fetus during pregnancy.73  Further research into 
the use of any currently available or novel forms of hormone therapy 
will be important in increasing bone mineral density in athletes with 
functional amenorrhoea.
Summary
Low energy availability, menstrual function and altered bone mineral 
density, in isolation or in combination, continue to pose significant 
health risks to female athletes.  We continue to see progress in de-
termining the aetiology, pathophysiology, recognition, diagnosis and 
management of the triad disorders.  All those who work with female 
athletes should remain vigilant in the education, recognition and 
treatment of athletes at risk.  Continued advancement of research 
efforts and knowledge of the triad disorders aiding in the develop-
ment of prevention and treatment strategies will allow all women to 
continue to enjoy the benefits of regular exercise and physical activ-
ity throughout their lives.  
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